179 related articles for article (PubMed ID: 11332317)
41. Cross-trial comparison of different AIs.
Vakaet L
Breast J; 2009; 15(5):544; author reply 545. PubMed ID: 19601953
[No Abstract] [Full Text] [Related]
42. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
[No Abstract] [Full Text] [Related]
43. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.
Delea TE; El-Ouagari K; Karnon J; Sofrygin O
Breast Cancer Res Treat; 2008 Apr; 108(3):375-87. PubMed ID: 17653859
[TBL] [Abstract][Full Text] [Related]
44. Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.
Gaston C; Kolesar J
Clin Adv Hematol Oncol; 2008 Nov; 6(11):825-33. PubMed ID: 19194367
[TBL] [Abstract][Full Text] [Related]
45. [Recent advance in adjuvant therapy for breast cancer].
Shimizu C; Watanabe T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
[TBL] [Abstract][Full Text] [Related]
46. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
Spicer J; Ellis P
Cancer Lett; 2007 Apr; 248(2):165-74. PubMed ID: 16919870
[TBL] [Abstract][Full Text] [Related]
47. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Monnier AM
Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
[TBL] [Abstract][Full Text] [Related]
48. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
[TBL] [Abstract][Full Text] [Related]
49. [Standards, Options and Recommendations (SOR) on hormone therapy in nonmetastatic cancer of the breast]].
Vennin P
Bull Cancer; 2000 Dec; 87(12):948-50. PubMed ID: 11174127
[No Abstract] [Full Text] [Related]
50. Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline.
De Vos FY; van Laarhoven HW; Laven JS; Themmen AP; Beex LV; Sweep CG; Seynaeve C; Jager A
Crit Rev Oncol Hematol; 2012 Nov; 84(2):252-60. PubMed ID: 22795229
[TBL] [Abstract][Full Text] [Related]
51. Management of primary breast cancer: an update.
Thürlimann B; Müller A; Senn HJ
Onkologie; 2004 Apr; 27(2):175-9. PubMed ID: 15138352
[TBL] [Abstract][Full Text] [Related]
52. Variation in use of adjuvant tamoxifen.
Davies C; McGale P; Peto R
Lancet; 1998 May; 351(9114):1487-8. PubMed ID: 9605808
[No Abstract] [Full Text] [Related]
53. [Clinical practice guideline for breast cancer].
Takatsuka Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():175-81. PubMed ID: 17682154
[No Abstract] [Full Text] [Related]
54. Breast cancer treatment and older women.
Kent H
CMAJ; 1999 Jul; 161(1):15. PubMed ID: 10420852
[No Abstract] [Full Text] [Related]
55. Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?
Bramwell VH; Pritchard KI
Eur J Cancer; 1999 Nov; 35(12):1625-7. PubMed ID: 10674005
[No Abstract] [Full Text] [Related]
56. Compliance with practice guidelines for node-negative breast cancer.
Olivotto A; Coldman AJ; Hislop TG; Trevisan CH; Kula J; Goel V; Sawka C
J Clin Oncol; 1997 Jan; 15(1):216-22. PubMed ID: 8996145
[TBL] [Abstract][Full Text] [Related]
57. [Treatment guidelines for systemic adjuvant therapy of breast cancer].
Watanabe T; Mukai H
Nihon Rinsho; 2006 Mar; 64(3):419-23. PubMed ID: 16529030
[TBL] [Abstract][Full Text] [Related]
58. Weight gain in women receiving adjuvant chemotherapy for breast cancer.
Faber-Langendoen K
JAMA; 1996 Sep; 276(11):855-6. PubMed ID: 8782620
[No Abstract] [Full Text] [Related]
59. Self-management strategies adopted by breast cancer survivors to improve their adherence to tamoxifen.
Sarradon-Eck A; Pellegrini I; Largillier R; Duran S; Tallet A; Tarpin C; Julian-Reynier C
Breast J; 2012; 18(4):389-91. PubMed ID: 22640035
[No Abstract] [Full Text] [Related]
60. Multifocal male breast cancer: a case report.
McQueen A; Cox J; Desai S; Moore R
Clin Breast Cancer; 2007 Apr; 7(7):570-2. PubMed ID: 17509167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
